Akebia Therapeutics, Inc. (AKBA)

Latest Insider Confidence Score

2026Q1

46.2
Bearish

Company insider confidence (by quarter)

2014Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Satter Muneer A Director 3,037,042 Jul 11, 2017
Novo A/S 10% Owner 1,333,797 Mar 26, 2014
Novartis Bioventures Ltd 10% Owner 1,329,314 Mar 27, 2014
Burke Steven Keith SVP, Chief Medical Officer 809,090 Mar 4, 2025
Dahan Michel COO 672,092 May 14, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 4, 2026 Mar 5, 2026 Butler John P. CEO Buy 82.5 +69,270 2.00% ✗ $86.6K
Feb 2, 2026 Feb 4, 2026 Malabre Richard C SVP, Chief Accounting Officer Sell 26.3 -49,524 -14.19% ✓ $68.8K
Feb 2, 2026 Feb 4, 2026 Grund Nicholas Chief Commercial Officer Sell 26.3 -84,829 -13.12% ✓ $117.9K
Feb 2, 2026 Feb 4, 2026 Burke Steven Keith SVP, Chief Medical Officer Sell 33.8 -67,658 -6.66% ✓ $94K
Feb 2, 2026 Feb 4, 2026 Rucci Carolyn M. SVP, Chief Legal Officer Sell 26.3 -69,772 -10.60% ✓ $97K
Feb 2, 2026 Feb 4, 2026 Ostrowski Erik CFO Sell 40.6 -34,951 -4.94% ✓ $48.6K
Feb 2, 2026 Feb 4, 2026 Butler John P. CEO Sell 37.5 -166,055 -4.58% ✓ $474.4K
Jan 30, 2026 Feb 3, 2026 Grund Nicholas Chief Commercial Officer Neutral 90.0 +204,000 46.09% ✗ -
Jan 30, 2026 Feb 3, 2026 Burke Steven Keith SVP, Chief Medical Officer Neutral 90.0 +204,000 25.12% ✗ -
Jan 30, 2026 Feb 3, 2026 Rucci Carolyn M. SVP, Chief Legal Officer Neutral 90.0 +190,000 40.59% ✗ -
Jan 30, 2026 Feb 3, 2026 Malabre Richard C SVP, Chief Accounting Officer Neutral 90.0 +79,000 29.27% ✗ -
Jan 30, 2026 Feb 3, 2026 Ostrowski Erik CFO Neutral 90.0 +204,000 40.51% ✗ -
Jan 30, 2026 Feb 3, 2026 Butler John P. CEO Neutral 90.0 +743,000 25.79% ✗ -
Feb 3, 2026 Rucci Carolyn M. SVP, Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 Ostrowski Erik CFO Sell 28.8 -41,314 -7.58% ✓ $151.6K
Jun 10, 2025 Jun 11, 2025 ZUMWALT LEANNE M Director Neutral 90.0 +35,700 48.44% ✗ -
Jun 10, 2025 Jun 11, 2025 ADAMS ADRIAN Director Neutral 90.0 +35,700 21.66% ✗ -
Jun 10, 2025 Jun 11, 2025 Wolf Myles Director Neutral 90.0 +35,700 36.55% ✗ -
Jun 10, 2025 Jun 11, 2025 Smith Cynthia Director Neutral 90.0 +35,700 28.51% ✗ -
Jun 10, 2025 Jun 11, 2025 ROGERS MICHAEL W Director Neutral 90.0 +35,700 28.33% ✗ -
Jun 10, 2025 Jun 11, 2025 GILMAN STEVEN C Director Neutral 90.0 +35,700 30.48% ✗ -
Jun 10, 2025 Jun 11, 2025 FRIESON RON Director Neutral 90.0 +35,700 38.06% ✗ -
Jun 9, 2025 Jun 11, 2025 Malabre Richard C SVP, Chief Accounting Officer Sell 32.5 -15,000 -5.32% ✓ $60.2K
Jun 4, 2025 Jun 5, 2025 Malabre Richard C SVP, Chief Accounting Officer Sell 41.3 -13,334 -4.76% ✓ $47.1K
Mar 3, 2025 Mar 4, 2025 Butler John P. CEO Sell 45.0 -46,409 -1.59% ✓ $84.9K
Mar 3, 2025 Mar 4, 2025 Burke Steven Keith SVP, Chief Medical Officer Sell 51.3 -7,144 -0.88% ✓ $13.1K
Jan 31, 2025 Feb 4, 2025 Butler John P. CEO Sell 97.5 +556,750 23.52% ✓ $302.9K
Jan 31, 2025 Feb 4, 2025 Burke Steven Keith SVP, Chief Medical Officer Sell 95.0 +144,394 21.49% ✓ $106.1K
Jan 31, 2025 Feb 4, 2025 Malabre Richard C SVP, Chief Accounting Officer Sell 95.0 +54,798 24.31% ✓ $63.4K
Jan 31, 2025 Feb 4, 2025 Grund Nicholas Chief Commercial Officer Sell 95.0 +139,279 45.92% ✓ $116.8K
Jan 31, 2025 Feb 4, 2025 Ostrowski Erik CFO Neutral 90.0 +194,900 55.69% ✗ -
Jan 17, 2025 Jan 22, 2025 FRIESON RON Director Neutral 52.5 - 0.00% ✗ -
Jun 28, 2024 Jul 2, 2024 Ostrowski Erik CFO Neutral 90.0 +350,000 100.00% ✗ -
Jun 26, 2024 Ostrowski Erik CFO Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Wolf Myles Director Neutral 90.0 +30,000 44.33% ✗ -
Jun 6, 2024 Jun 10, 2024 Smith Cynthia Director Neutral 90.0 +30,000 31.50% ✗ -
Jun 6, 2024 Jun 10, 2024 ROGERS MICHAEL W Director Neutral 90.0 +30,000 31.24% ✗ -
Jun 6, 2024 Jun 10, 2024 GILMAN STEVEN C Director Neutral 90.0 +30,000 34.43% ✗ -
Jun 6, 2024 Jun 10, 2024 FRIESON RON Director Neutral 90.0 +30,000 68.65% ✗ -
Jun 6, 2024 Jun 10, 2024 ZUMWALT LEANNE M Director Neutral 90.0 +30,000 68.65% ✗ -
Jun 6, 2024 Jun 10, 2024 ADAMS ADRIAN Director Neutral 90.0 +30,000 22.26% ✗ -
May 13, 2024 May 14, 2024 Hadas Nicole R. SVP, Chief Legal Officer Sell 48.8 -12,016 -1.81% ✓ $15.1K
May 13, 2024 May 14, 2024 Dahan Michel COO Sell 41.3 -34,840 -4.93% ✓ $43.9K
Aug 25, 2023 May 9, 2024 Burke Steven Keith SVP, Chief Medical Officer Sell 26.3 -27,000 -3.88% ✗ $31.1K
Feb 29, 2024 Mar 1, 2024 Dahan Michel COO Sell 46.3 -8,661 -1.21% ✗ $13.7K
Feb 29, 2024 Mar 1, 2024 Hadas Nicole R. SVP, Chief Legal Officer Sell 50.0 -5,974 -0.89% ✗ $9.4K
Feb 29, 2024 Mar 1, 2024 Butler John P. CEO Sell 42.5 -46,570 -1.93% ✗ $73.6K
Feb 29, 2024 Mar 1, 2024 Burke Steven Keith SVP, Chief Medical Officer Sell 46.3 -7,169 -1.02% ✗ $11.3K
Feb 27, 2024 Feb 29, 2024 Hadas Nicole R. SVP, Chief Legal Officer Sell 48.8 -7,411 -1.10% ✓ $11.3K
Feb 27, 2024 Feb 29, 2024 Dahan Michel COO Sell 46.3 -10,744 -1.48% ✗ $16.3K
Feb 27, 2024 Feb 29, 2024 Burke Steven Keith SVP, Chief Medical Officer Sell 48.8 -8,367 -1.18% ✓ $12.7K
Feb 27, 2024 Feb 29, 2024 Butler John P. CEO Sell 42.5 -37,733 -1.54% ✗ $57.4K
Jan 31, 2024 Feb 2, 2024 Grund Nicholas Chief Commercial Officer Neutral 90.0 +303,300 100.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Malabre Richard C Chief Accounting Officer Neutral 90.0 +223,950 100.00% ✗ -
Jan 31, 2024 Feb 2, 2024 Dahan Michel COO Neutral 90.0 +149,300 25.87% ✗ -
Jan 31, 2024 Feb 2, 2024 Snow Ellen CFO Neutral 90.0 +149,300 40.35% ✗ -
Jan 31, 2024 Feb 2, 2024 Hadas Nicole R. SVP, Chief Legal Officer Neutral 90.0 +149,300 28.31% ✗ -
Jan 31, 2024 Feb 2, 2024 Butler John P. CEO Sell 95.0 +557,011 29.44% ✗ $78.1K
Jan 31, 2024 Feb 2, 2024 Burke Steven Keith SVP, Chief Medical Officer Sell 91.3 +177,889 33.34% ✗ $40.8K
Jan 18, 2024 Grund Nicholas Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Jan 18, 2024 Malabre Richard C Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jul 31, 2023 Aug 1, 2023 Snow Ellen CFO Neutral 90.0 +370,000 100.00% ✗ -
Jul 18, 2023 Snow Ellen CFO Neutral 52.5 - 0.00% ✗ -
Jun 6, 2023 Jun 8, 2023 ZUMWALT LEANNE M Director Neutral 90.0 +30,000 218.98% ✗ -
Jun 6, 2023 Jun 8, 2023 ROGERS MICHAEL W Director Neutral 90.0 +30,000 45.43% ✗ -
Jun 6, 2023 Jun 8, 2023 FRIESON RON Director Neutral 90.0 +30,000 218.98% ✗ -
Jun 6, 2023 Jun 8, 2023 Wolf Myles Director Neutral 90.0 +30,000 79.62% ✗ -
Jun 6, 2023 Jun 8, 2023 ADAMS ADRIAN Director Neutral 90.0 +30,000 28.63% ✗ -
Jun 6, 2023 Jun 8, 2023 Smith Cynthia Director Neutral 90.0 +30,000 45.99% ✗ -
Jun 6, 2023 Jun 8, 2023 GILMAN STEVEN C Director Neutral 90.0 +30,000 52.51% ✗ -
May 24, 2023 May 25, 2023 Hadas Nicole R. SVP, Chief Legal Officer Sell 95.0 +136,814 35.30% ✗ $77.3K
May 24, 2023 May 25, 2023 Dahan Michel COO Sell 95.0 +104,522 22.26% ✗ $116.8K
May 16, 2023 May 18, 2023 Burke Steven Keith SVP, Chief Medical Officer Sell 42.5 -63,567 -10.70% ✗ $67.9K
May 16, 2023 May 18, 2023 Spellman David A CFO Sell 42.5 -63,567 -12.46% ✗ $67.9K
May 12, 2023 May 16, 2023 Hadas Nicole R. SVP, Chief Legal Officer Neutral 90.0 +100,000 34.78% ✗ -
May 12, 2023 May 16, 2023 Dahan Michel COO Neutral 90.0 +200,000 74.21% ✗ -
Mar 1, 2023 Mar 3, 2023 Butler John P. CEO Sell 42.5 -91,868 -4.64% ✗ $80.6K
Mar 1, 2023 Mar 3, 2023 Hadas Nicole R. SVP, Chief Legal Officer Sell 46.3 -13,034 -4.34% ✗ $11.4K
Mar 1, 2023 Mar 3, 2023 Burke Steven Keith SVP, Chief Medical Officer Sell 46.3 -14,123 -2.32% ✗ $12.4K
Mar 1, 2023 Mar 3, 2023 Dahan Michel COO Sell 46.3 -20,412 -7.04% ✗ $17.9K
Mar 1, 2023 Mar 3, 2023 Spellman David A CFO Sell 47.5 -7,210 -1.39% ✗ $6.3K
Feb 27, 2023 Mar 1, 2023 Butler John P. CEO Sell 46.3 -38,632 -1.91% ✗ $31.4K
Feb 27, 2023 Mar 1, 2023 Burke Steven Keith SVP, Chief Medical Officer Sell 47.5 -7,539 -1.22% ✗ $6.1K
Feb 27, 2023 Mar 1, 2023 Dahan Michel COO Sell 47.5 -10,090 -3.36% ✗ $8.2K
Feb 27, 2023 Mar 1, 2023 Spellman David A CFO Sell 47.5 -7,539 -1.44% ✗ $6.1K
Feb 27, 2023 Mar 1, 2023 Hadas Nicole R. SVP, Chief Legal Officer Sell 47.5 -6,677 -2.17% ✗ $5.4K
Jan 31, 2023 Feb 2, 2023 Butler John P. CEO Neutral 90.0 +293,125 16.98% ✗ -
Jan 31, 2023 Feb 2, 2023 Spellman David A CFO Neutral 90.0 +196,200 59.71% ✗ -
Jan 31, 2023 Feb 2, 2023 Burke Steven Keith SVP, Chief Medical Officer Neutral 90.0 +196,200 46.77% ✗ -
Aug 31, 2022 Sep 1, 2022 Burke Steven Keith SVP, Chief Medical Officer Sell 52.5 -1,147 -0.27% ✗ $415.8
Jun 8, 2022 Jun 10, 2022 Spellman David A CFO Neutral 90.0 +200,000 155.52% ✗ -
Jun 8, 2022 Jun 9, 2022 ZUMWALT LEANNE M Director Neutral 90.0 +13,700 100.00% ✗ -
Jun 8, 2022 Jun 9, 2022 Wolf Myles Director Neutral 90.0 +13,700 57.13% ✗ -
Jun 8, 2022 Jun 9, 2022 Smith Cynthia Director Neutral 90.0 +13,700 26.58% ✗ -
Jun 8, 2022 Jun 9, 2022 ROGERS MICHAEL W Director Neutral 90.0 +13,700 26.18% ✗ -
Jun 8, 2022 Jun 9, 2022 GILMAN STEVEN C Director Neutral 90.0 +13,700 31.55% ✗ -
Jun 8, 2022 Jun 9, 2022 FRIESON RON Director Neutral 90.0 +13,700 100.00% ✗ -
Jun 8, 2022 Jun 9, 2022 ADAMS ADRIAN Director Neutral 90.0 +13,700 15.04% ✗ -
Jun 3, 2022 Jun 7, 2022 GILMAN STEVEN C Director Sell 33.8 -4,567 -9.52% ✓ $1.7K
May 12, 2022 May 16, 2022 Burke Steven Keith SVP, Chief Medical Officer Neutral 90.0 +200,000 91.89% ✗ -